年龄相关膝关节滑液生物标志物类型与浓度变化预测前交叉韧带重建后5至10年结局
这项队列研究前瞻性纳入100例前交叉韧带重建患者,评估年龄与术前滑液生物标志物浓度的关联及其对长期预后的影响。结果显示年龄增长与较低的TIMP-1浓度独立相关,且年龄修饰了TIMP-1、TIMP-2和MIP-1β与患者报告结局的关联,提示解读生物标志物时需考虑年龄。
要点
- 年龄增长与术前滑液TIMP-1浓度降低独立相关,且该关联受症状持续时间修饰。
- 年龄增长与更差的长期患者报告结局及达到最小临床重要差异的可能性降低相关。
- 调整年龄后,MIP-1β、MMP-3、TIMP-2和bFGF浓度分别与功能、疼痛、活动水平和身体功能相关。
核心结论
- 前交叉韧带重建时患者年龄与滑液生物标志物表达的选择性改变及长期临床结局相关。
- 年龄修饰了关键生物标志物的预后意义,强调在生物标志物解读和风险分层中纳入年龄的重要性。
研究设计与样本
- 共纳入100例患者,平均年龄30.8±9.5岁;术前切皮前抽取滑液并定量促炎和抗炎生物标志物浓度。
- 术后至少5年完成患者报告结局测量,包括疼痛视觉模拟量表、Lysholm量表、Tegner活动量表和膝关节损伤与骨关节炎结局评分-身体功能简表。
主要发现
- 年龄增长与较低的术前滑液TIMP-1浓度独立相关(β = -0.0775;P = .014)。
- 年龄与TIMP-1浓度的关联受症状持续时间修饰,在<3.0个月和>8.5个月时效应显著。
- 软骨损伤严重程度未中介年龄与生物标志物的关联。
- 年龄增长与更差的长期患者报告结局相关,且达到疼痛、功能和活动方面最小临床重要差异的可能性降低。
- 调整年龄后,较高的MIP-1β浓度与更差的功能结局相关,较高的MMP-3浓度与更重的疼痛相关,较高的TIMP-2浓度与更低的活动水平相关,较高的bFGF浓度与更好的身体功能相关。
临床怎么用
- 解读前交叉韧带损伤后滑液生物标志物时需考虑患者年龄,年龄可能影响生物标志物的预后价值。
- 年龄增长与前交叉韧带重建后长期患者报告结局较差及达到最小临床重要差异可能性降低相关,可用于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Synovial fluid biomarkers reflect the intra-articular response to an anterior cruciate ligament (ACL) rupture and may provide insight into biological processes associated with posttraumatic joint degeneration. While increasing age has been associated with inferior clinical outcomes after ACL reconstruction, age-dependent differences in biomarker expression and their relationship to longer term outcomes remain unclear. PURPOSE/HYPOTHESIS: The purpose of this study was to evaluate the association between patient age and preoperative synovial biomarker concentrations after an ACL injury to determine whether age modifies biomarker-outcome relationships at longer term follow-up. The authors hypothesized that increasing age would be associated with an elevated inflammatory response and modify biomarker-outcome associations. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients undergoing ACL reconstruction between July 2011 and December 2020 were prospectively enrolled. Synovial fluid was aspirated before incision, and concentrations of proinflammatory and anti-inflammatory biomarkers were quantified. Patients completed patient-reported outcome (PRO) measures, including the visual analog scale for pain, Lysholm scale, Tegner Activity Scale, and Knee injury and Osteoarthritis Outcome Score-Physical Function Short Form, at a minimum of 5 years postoperatively. Multivariable regression assessed associations between age and biomarker concentrations. Conditional process analysis evaluated moderation by symptom duration and mediation by cartilage injury severity. Associations between age and long-term PROs were assessed using multivariable regression and minimal clinically important difference analyses. RESULTS: A total of 100 patients were included (mean age, 30.8 ± 9.5 years). Increasing age was independently associated with lower preoperative synovial TIMP-1 concentrations (β = -0.0775; P = .014). This association was moderated by symptom duration, with significant effects at <3.0 and >8.5 months. Cartilage injury severity did not mediate age-biomarker associations. Increasing age was associated with worse long-term PROs and the decreased likelihood of achieving the minimal clinically important difference for pain, function, and activity. After adjusting for age, higher MIP-1β concentrations were associated with worse functional outcomes, higher MMP-3 concentrations were associated with greater pain, higher TIMP-2 concentrations were associated with lower activity levels, and higher bFGF concentrations were associated with improved physical function. Significant age-dependent interactions were observed for TIMP-1, TIMP-2, and MIP-1β with selected PROs. Age-stratified analysis demonstrated heterogeneous biomarker-outcome associations. CONCLUSION: Patient age at the time of ACL reconstruction was associated with selective alterations in synovial biomarker expression and long-term clinical outcomes. Age modified the prognostic significance of key biomarkers, highlighting the importance of incorporating age into biomarker interpretation and risk stratification after an ACL injury.
引用
- Ehlers M, Kurtz JL, Montgomery SR, et al. Age-Dependent Variations in Knee Synovial Fluid Biomarker Type and Concentration Predict 5- to 10-Year Outcomes After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2026. PMID: 42781773. doi:10.1177/03635465261485707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。